This is one of two volumes covering the latest developments in the field of purinergic and pyrimidinergic transmission, going into the roles of those signaling systems in tissue function and pathophysiology and advances in developing potential new medications based on the modulation of P1 and P2 receptor signaling processes. HEP 151 II centers on the cardiovascular, renal, immune and endocrine systems.
This two-part volume is an update and objective state of the art of the current knowledge in the field, with particular emphasis on the development of novel therapeutic entities that may prove useful in several diseases by targeting the purinergic/pyrimidinergic system
Maria P. Abracchio
Diabetes Pathophysiologie Purine Purines Pyrimidine adenosine bone endothelium entities new therapeutic pathophysiology physiology receptor signaling signaling system tissue